MBMichaela Brtnikova

Michaela Brtnikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michaela Brtnikova has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparing different forms of structured follow-up support in the treatment of multiple health risks for chronic disease: a randomized controlled trial protocol

    by Emily R. Dunston, Amy G. Huebschmann, Ermyas Birru, Michaela Brtnikova, Bryan S. Ford, Rebekah Gomes, Kiana A. White, Andrea Nederveld, Demetria M. Bolden, Monica Perez Jolles, et al.

    Background: Primary care clinics need effective, low-cost tools to screen for and address multiple health risks — and technology can provide important efficiencies. My Own Health Report (MOHR) is a web-based intervention with 3 core functions: (1) risk flagging; (2) goal-setting for patient-prioritized risks; and (3) providing resources. A prior randomized trial in primary care settings showed that MOHR was feasible and effective. However, we identified two key gaps : a need for a flexible menu of delivery options to adopt and sustain MOHR and a pragmatic way to provide structured follow-up. Methods/design: We developed and pilot-tested two distinct primary implementation strategies to provide structured follow-up: the first primary strategy, termed “Reminder-Resource message ( R 2 message) ,” involves automated motivational text message nudges to remind patients of their MOHR goal and point to resources. The second, “R 2 navigation ,” involves personal support - community health worker phone calls to deliver reminders and resources. Each primary strategy is paired with additional secondary strategies that together address the contextual determinants of successful implementation and sustainment identified using our Pragmatic Robust Implementation and Sustainability Model (PRISM). We engaged clinic staff, patients, and community partners to finalize the R 2 message and R 2 navigation strategies and secondary strategies. This individually randomized, type 2 hybrid effectiveness-implementation trial will enroll 1,000 adult patients with at least two cancer risks (including both insufficient physical activity and fruit/vegetable intake). We will evaluate the outcomes and cost-effectiveness of R 2 message and R 2 navigation alone or in combination in 12 primary care clinics including both (a) large metropolitan health system and (b) rural-serving clinics. Expected outcomes include: (1) improvement in behavioral risk factors; (2) implementation outcomes – including representative engagement with R 2 message and R 2 navigation, and cost; and (3) improvement in practice value outcomes, including patient experience ratings. Based on the trial findings, we will co-develop an implementation, adaptation and sustainment guide for the most cost-effective implementation strategy. Conclusions: We expect the implementation strategies compared will produce different levels of representative engagement, behavior change, cost, and practice value. These findings will inform pragmatic ways to improve outcomes important to patients, primary care, and society. Trial Registration# at ClinicalTrials.gov: NCT07569224 (Registration date: 04/29/2026).

  • Open Access

    A method for achieving high response rates in national surveys of U.S. primary care physicians

    by Michaela Brtnikova, Lori A Crane, Mandy A Allison, Laura P Hurley, Brenda L Beaty, Allison Kempe

    Physician questionnaires are commonly used in health services research; however, many survey studies are limited by low response rate. We describe the effectiveness of a method to maximize survey response without using incentives, the effectiveness of survey reminders over time, and differences in response rates based on survey mode and primary care specialty. As part of a study to assess vaccine policy issues, 13 separate surveys were conducted by internet and mail over the period of 2008 to 2013. Surveys were conducted among pre-recruited networks of pediatricians, family physicians and general internists. Each network was active for 2 years and responded to 3–6 surveys. Physicians who indicated preference to respond through an online survey received up to 9 e-mailed requests to complete the questionnaire and up to 2 mailed questionnaires. Physicians who chose to respond by mail received up to 3 mailed questionnaires and a reminder postcard. For 6 of the 13 surveys conducted over the 6 year period, an additional mailing using a hand-addressed envelope was mailed to non-responders at the end of the usual protocol. Effectiveness of survey methods was measured by response rates. The overall response rates varied from 66‒83%. Response rates declined 17 percentage-points on average between the first and last surveys administered within each physician network. The internet group consistently had higher response rates than the mail group (74% vs. 62% on average). An additional mailing in a hand-written envelope boosted the final response rate by 11 percentage-points. Self-selection of survey mode, multiple reminders, and hand-written envelopes are effective methods for maximizing response rates in physician surveys.


  • Open Access

    Vaccine Refusal Among Pregnant Women: A National Survey of Obstetrician-Gynecologists

    by Sean O’leary, Laura Riley, Megan C Lindley, Mandy Allison, Lori Crane, Laura Hurley, Brenda Beaty, Michaela Brtnikova, Alison Albert, Alison Fisher, et al.

    Little is known about vaccine refusal among pregnant women. Our objectives were to describe, among a nationally representative sample of obstetrician-gynecologists (ob-gyns): 1) perception of frequency of and reasons for vaccine refusal among pregnant women; and 2) strategies used to address vaccine refusal and perceived effectiveness of those strategies. E-mail and mail survey among ob-gyns conducted 3–6/2016. The response rate was 69% (331/477). Pregnant women more commonly refused influenza (flu) vaccine compared with tetanus-diphtheria-acellular pertussis (Tdap) vaccine (Table 1). Ob-gyns perceive refusal of flu vaccine is more common among their pregnant patients than refusal of Tdap. Emphasizing the risk of disease to the fetus may be an effective strategy to increase uptake. It will be important to validate these findings in a patient sample. All authors: No reported disclosures. Percent of Pregnant Women Refusing Vaccines When Told They Need it* *Row % represents proportion of ob-gyns endorsing the response. The most common reasons reported as contributing to refusal of vaccines ‘a lot’ were belief that flu vaccine makes them sick (48%), belief that they are unlikely to get a vaccine-preventable disease (VPD) (38%), general worries about vaccines (32%), desire to maintain a ‘natural’ pregnancy (31%), and concern that their child could develop autism as a result of maternal vaccination (25%). Physicians used several strategies to address refusal (Table 2). The strategy perceived as most effective was stating that not getting vaccinated puts the fetus/newborn at risk. Table 2.# #Statements pertain to generic vaccination.


  • 37: Obstetrician/gynecologists: a critical role as vaccinators of adult women

    by L. Riley, Sean T. O’lEary, Laura P. Hurley, Mandy A. Allison, Lori A. Crane, Michaela Brtnikova, Brenda T. Beaty, Noushin Berdjis, Megan C. Lindley, Allison Kempe

  • Open Access

    Provider Attitudes Regarding Vaccine Tracking Systems in Pediatric Practices

    by Sean T. O'LEary, Laura P. Hurley, Erin D. Kennedy, Lori A. Crane, Michaela Brtnikova, Mandy A. Allison, Warren Williams, Brenda L. Beaty, Andrea Jimenez-Zambrano, Allison Kempe